What is the recommended dose of Robitussin (Guaifenesin) for adults and children with normal renal and hepatic function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Robitussin (Guaifenesin) Recommended Dosing

For adults and children 12 years and older, the recommended dose of guaifenesin is 200-400 mg every 4 hours (not exceeding 6 doses in 24 hours), or 1200 mg every 12 hours for extended-release formulations. 1

Adult Dosing

  • Immediate-release formulation: 10-20 mL (200-400 mg) every 4 hours, maximum 6 doses per 24 hours 1
  • Extended-release formulation: 1200 mg (two 600 mg tablets) every 12 hours 2, 3
  • The extended-release formulation provides bioequivalent steady-state exposure to the immediate-release formulation while reducing dosing frequency from every 4 hours to every 12 hours 2

Pediatric Dosing (Immediate-Release)

Children 6 to under 12 years:

  • 5-10 mL (100-200 mg) every 4 hours, maximum 6 doses per 24 hours 1

Children 2 to under 6 years:

  • 2.5-5 mL (50-100 mg) every 4 hours, maximum 6 doses per 24 hours 1

Children under 2 years:

  • Consult a physician before use 1

Administration Considerations

  • Food effects: Extended-release guaifenesin can be taken with or without food, though Tmax is delayed in the fed state compared to fasted state 2
  • Multiple daily doses are required with immediate-release formulations to maintain 24-hour therapeutic effect 4
  • The dosing range allows flexible dose titration to optimize plasma concentrations for symptom relief 4

Safety Profile

  • Guaifenesin demonstrates a well-established and favorable safety profile in both adult and pediatric populations 4
  • In a post-marketing surveillance study of 552 adults taking extended-release guaifenesin 1200 mg every 12 hours for 7 days, all adverse events were mild in severity with no serious adverse events or deaths 3
  • The most common adverse events include gastrointestinal symptoms, nervous system effects, and psychiatric symptoms, all mild in nature 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.